Interactions between Therapeutic Proteins and Acrylic Acid Leachable

References

1. 1.↵
   1. Markovic I.

   Evaluation of safety and quality impact of extractable and leachable substances in therapeutic biologic protein products: a risk-based perspective. Expert. Opin. Drug Saf. 2007, 6 (5), 487–491.

   OpenUrlCrossRefPubMedWeb of Science
2. 2.↵
   1. Schellekens H.,
   2. Jiskoot W.

   Eprex-associated pure red cell aplasia and leachates. Nat. Biotechnol. 2006, 24 (6), 613–614.

   OpenUrlCrossRefPubMedWeb of Science
3. 3.↵
   1. Baldwin R. N.

   Contamination of insulin by silicone oil: a potential hazard of plastic insulin syringes. Diabet. Med. 1988, 5 (8), 789–790.

   OpenUrlPubMed
4. 4.↵
   1. Jiang Y.,
   2. Nashed-Samuel Y.,
   3. Li C.,
   4. Liu W.,
   5. Pollastrini J.,
   6. Mallard D.,
   7. Wen Z. Q.,
   8. Fujimori K.,
   9. Pallitto M.,
   10. Donahue L.,
   11. Chu G.,
   12. Torraca G.,
   13. Vance A.,
   14. Mire-Sluis T.,
   15. Freund E.,
   16. Davis J.,
   17. Narhi L.

   Tungsten-induced protein aggregation: solution behavior. J. Pharm. Sci. 2009, 98 (12), 4695–4710.

   OpenUrlCrossRefPubMed
5. 5.↵
   1. Nassar M. N.,
   2. Nesarikar V. V.,
   3. Lozano R.,
   4. Huang Y.,
   5. Palaniswamy V.

   Degradation of a lyophilized formulation of BMS-204352: identification of degradants and role of elastomeric closures. Pharm. Dev. Technol. 2005, 10 (2), 227–232.

   OpenUrlPubMed
6. 6.↵
   1. Ren D.,
   2. Pipes G. D.,
   3. Liu D.,
   4. Shih L. Y.,
   5. Nichols A. C.,
   6. Treuheit M. J.,
   7. Brems D. N.,
   8. Bondarenko P. V.

   An improved trypsin digestion method minimizes digestion-induced modifications on proteins. Anal. Biochem. 2009, 392 (1), 12–21.

   OpenUrlCrossRefPubMed
7. 7.↵
   1. Bolgar M. S.,
   2. Yang C. Y.,
   3. Gaskell S. J.

   First direct evidence for lipid/protein conjugation in oxidized human low density lipoprotein. J. Biol. Chem. 1996, 271 (45), 27999–28001.

   OpenUrlAbstract/FREE Full Text
8. 8.↵
   1. Sudmeier J. L.,
   2. Bradshaw E. M.,
   3. Haddad K. E.,
   4. Day R. M.,
   5. Thalhauser C. J.,
   6. Bullock P. A.,
   7. Bachovchin W. W.

   Identification of histidine tautomers in proteins by 2D 1H/13C(delta2) one-bond correlated NMR. J. Am. Chem. Soc. 2003, 125 (28), 8430–8431.

   OpenUrlCrossRefPubMedWeb of Science
9. 9.↵
   1. Elfarra A. A.

   1. Elfarra A. A.,
   2. Krause R. J.

   Chapter 3. Michael Addition-Elimination Reactions: Roles in Toxicity and Potential New Therapeutic Applications. In Advances in Bioactivation Research; Elfarra A. A. Ed.; Springer, 2008, 57–68.
10. 10.↵
    1. Doorn J. A.,
    2. Petersen D. R.

    Covalent adduction of nucleophilic amino acids by 4-hydroxynonenal and 4-oxononenal. Chem. Biol. Interact. 2003, 143–144, 93–100.

    OpenUrl
11. 11.↵
    1. Liu H.,
    2. Gaza-Bulseco G.,
    3. Faldu D.,
    4. Chumsae C.,
    5. Sun J.

    Heterogeneity of monoclonal antibodies. J. Pharm. Sci. 2008, 97 (7), 2426–2447.

    OpenUrlCrossRefPubMed
12. 12.↵
    1. Wang W.,
    2. Singh S.,
    3. Zeng D. L.,
    4. King K.,
    5. Nema S.

    Antibody structure, instability, and formulation. J. Pharm. Sci. 2007, 96 (1), 1–26.

    OpenUrlCrossRefPubMed